Papers
3
Total Citations
47
H-Index
3
About
Oscar Lin is a distinguished cytopathologist whose research has significantly advanced the field of telecytology and remote diagnostic medicine. Working at Memorial Sloan Kettering Cancer Center, Lin has been at the forefront of developing and implementing robotic telecytology systems that enable expert cytologic evaluation without requiring an on-site cytotechnologist or cytopathologist — a transformative innovation for satellite and underserved medical centers. Lin's most impactful contributions center on validating robotic telecytology as a clinically reliable solution for rapid on-site evaluation (ROSE) during fine needle aspirations and core biopsies. His 2017 studies, collectively garnering over 40 citations, rigorously documented both the implementation challenges and quality outcomes across more than 400 cases, establishing an evidence-based foundation for remote cytology practice. His subsequent 2020 work synthesizing the evolving landscape of telecytology further positioned him as a thought leader in this emerging subspecialty. Lin's research addresses a critical gap in modern healthcare: extending high-quality cytopathology expertise to facilities lacking dedicated specialists. By demonstrating that robotic telecytology meets clinical standards for diagnostic accuracy, his work has meaningful implications for patient access, procedural efficiency, and the future of digital pathology integration into routine clinical workflows.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Telecytology for Rapid On-Site Evaluation3 citations · 2020